NPRL2
GATOR1 complex protein NPRL2
Also known as: NPR2, NPR2L, NPRL2_HUMAN, TUSC4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WTW4
- Gene
- NPRL2
- Ensembl
- ENSG00000114388
- Chromosome
- 3
- Canonical length
- 380 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
Enables GTPase activator activity. Involved in cellular response to amino acid starvation; negative regulation of TORC1 signaling; and negative regulation of kinase activity. Part of GATOR1 complex. Is active in lysosomal membrane. Implicated in familial focal epilepsy with variable foci 2. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
380 residues, UniProt reviewed canonical sequence.
>Q8WTW4|NPRL2
1 MGSGCRIECI FFSEFHPTLG PKITYQVPED FISRELFDTV QVYIITKPEL QNKLITVTAM
61 EKKLIGCPVC IEHKKYSRNA LLFNLGFVCD AQAKTCALEP IVKKLAGYLT TLELESSFVS
121 MEESKQKLVP IMTILLEELN ASGRCTLPID ESNTIHLKVI EQRPDPPVAQ EYDVPVFTKD
181 KEDFFNSQWD LTTQQILPYI DGFRHIQKIS AEADVELNLV RIAIQNLLYY GVVTLVSILQ
241 YSNVYCPTPK VQDLVDDKSL QEACLSYVTK QGHKRASLRD VFQLYCSLSP GTTVRDLIGR
301 HPQQLQHVDE RKLIQFGLMK NLIRRLQKYP VRVTREEQSH PARLYTGCHS YDEICCKTGM
361 SYHELDERLE NDPNIIICWKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPRL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 19 nTPM
- tongue: 17 nTPM
- skeletal muscle: 16 nTPM
- liver: 12 nTPM
- choroid plexus: 12 nTPM
- parathyroid gland: 11 nTPM
Single-cell type
- late spermatids: 93 nCPM
- early spermatids: 91 nCPM
- late primary spermatocytes: 66 nCPM
- breast lactating cells: 39 nCPM
- oocytes: 37 nCPM
- cytotrophoblasts: 33 nCPM
Immune cell
- gdT-cell: 73 nTPM
- NK-cell: 64 nTPM
- MAIT T-cell: 64 nTPM
- memory CD8 T-cell: 63 nTPM
- total PBMC: 51 nTPM
- T-reg: 50 nTPM
Brain region
- hypothalamus: 11 nTPM
- midbrain: 10 nTPM
- white matter: 9 nTPM
- pons: 8.7 nTPM
- spinal cord: 8.6 nTPM
- cerebellum: 8.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NPRL2.
Disease | AllUniProt
Conditions NPRL2 is implicated in, by any mechanism.
- Epilepsy, familial focal, with variable foci 2 (FFEVF2) MIM:617116
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 167 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Epilepsy, familial focal, with variable foci 2
- Inborn genetic diseases
- Seizure
- Neonatal respiratory distress
- Familial focal epilepsy with variable foci
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.39
- gnomAD missense Z
- 1.64
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to amino acid starvation
- negative regulation of kinase activity
- negative regulation of TORC1 signaling
- positive regulation of autophagy
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nitrogen permease regulator 2-like
- Nitrogen permease regulator 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NPRL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPRL2 as an antibody target. Whether an autoantibody or antibody against NPRL2 could matter depends on whether native NPRL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPRL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NPRL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...